Recombinant Strategies For Biotechnology

While keeping one eye turned behind to ward off Big-Brother pharmaceutical company bear hugs, CEOs are now evaluating inter-firm mergers, strategic partnering and cross-licensing agreements.

October 1 1992 by Chief Executive